-
1
-
-
0141675219
-
Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England
-
DOI 10.1128/CDLI.10.5.780-786.2003
-
Andrews, N., R. Borrow, and E. Miller. 2003. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin. Diagn. Lab. Immunol. 10:780-786. (Pubitemid 37129487)
-
(2003)
Clinical and Diagnostic Laboratory Immunology
, vol.10
, Issue.5
, pp. 780-786
-
-
Andrews, N.1
Borrow, R.2
Miller, E.3
-
2
-
-
57549114614
-
Association of a bacteriophage with meningococcal disease in young adults
-
Bille, E., et al. 2008. Association of a bacteriophage with meningococcal disease in young adults. PLoS One 3:e3885.
-
(2008)
PLoS One
, vol.3
-
-
Bille, E.1
-
3
-
-
74549171099
-
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine
-
Borrow, R., et al. 2010. Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine. Clin. Vaccine Immunol. 17:154-159.
-
(2010)
Clin. Vaccine Immunol.
, vol.17
, pp. 154-159
-
-
Borrow, R.1
-
4
-
-
14844282302
-
Meningococcal surrogates of protection - Serum bactericidal antibody activity
-
DOI 10.1016/j.vaccine.2005.01.051
-
Borrow, R., P. Balmer, and E. Miller. 2005. Meningococcal surrogates of protection - serum bactericidal antibody activity. Vaccine 23:2222-2227. (Pubitemid 40341456)
-
(2005)
Vaccine
, vol.23
, Issue.17-18
, pp. 2222-2227
-
-
Borrow, R.1
Balmer, P.2
Miller, E.3
-
5
-
-
0036716435
-
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection
-
Burrage, M., et al. 2002. Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection. Infect. Immun. 70:4946-4954.
-
(2002)
Infect. Immun.
, vol.70
, pp. 4946-4954
-
-
Burrage, M.1
-
6
-
-
77952004260
-
Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: Effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity
-
Campbell, H., N. Andrews, R. Borrow, C. Trotter, and E. Miller. 2010. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity. Clin. Vaccine Immunol. 17:840-847.
-
(2010)
Clin. Vaccine Immunol.
, vol.17
, pp. 840-847
-
-
Campbell, H.1
Andrews, N.2
Borrow, R.3
Trotter, C.4
Miller, E.5
-
7
-
-
0026543812
-
Mortality in meningococcal disease
-
Cartwright, K., J. Strang, S. Reilly, and D. White. 1992. Mortality in meningococcal disease. BMJ 304:116.
-
(1992)
BMJ
, vol.304
, pp. 116
-
-
Cartwright, K.1
Strang, J.2
Reilly, S.3
White, D.4
-
8
-
-
33846042245
-
Lessons from meningococcal carriage studies
-
DOI 10.1111/j.1574-6976.2006.00052.x
-
Caugant, D. A., G. Tzanakaki, and P. Kriz. 2007. Lessons from meningococcal carriage studies. FEMS Microbiol. Rev. 31:52-63. (Pubitemid 46058820)
-
(2007)
FEMS Microbiology Reviews
, vol.31
, Issue.1
, pp. 52-63
-
-
Caugant, D.A.1
Tzanakaki, G.2
Kriz, P.3
-
9
-
-
79251607440
-
Updated recommendations for use of meningococcal conjugate vaccines. Advisory Committee on Immunization Practices (ACIP), 2010
-
CDC
-
CDC. 2011. Updated recommendations for use of meningococcal conjugate vaccines. Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb. Mortal. Wkly. Rep. 60:72-76.
-
(2011)
MMWR Morb. Mortal. Wkly. Rep.
, vol.60
, pp. 72-76
-
-
-
10
-
-
4944225305
-
Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children
-
DOI 10.1016/j.vaccine.2004.04.027, PII S0264410X0400372X
-
Collins, C. L., et al. 2004. Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children. Vaccine 22:4262-4269. (Pubitemid 39330349)
-
(2004)
Vaccine
, vol.22
, Issue.31-32
, pp. 4262-4269
-
-
Collins, C.L.1
Salt, P.2
McCarthy, N.3
Chantler, T.4
Lane, L.5
Hemme, F.6
Diggle, L.7
Buttery, J.8
Kitchin, N.R.E.9
Moxon, E.R.10
Pollard, A.J.11
-
11
-
-
0017344016
-
Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92
-
Glode, M. P., et al. 1977. Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. J. Infect. Dis. 135:94-104.
-
(1977)
J. Infect. Dis.
, vol.135
, pp. 94-104
-
-
Glode, M.P.1
-
12
-
-
0037094103
-
Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000
-
DOI 10.1086/340050
-
Healy, C. M., et al. 2002. Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000. Clin. Infect. Dis. 34:1323-1330. (Pubitemid 34507941)
-
(2002)
Clinical Infectious Diseases
, vol.34
, Issue.10
, pp. 1323-1330
-
-
Healy, C.M.1
Butler, K.M.2
Smith, E.O'B.3
Hensey, O.P.4
Bate, T.5
Moloney, A.C.6
MacMahon, P.7
Cosgrove, J.8
Cafferkey, M.T.9
-
13
-
-
79951681571
-
Persistence of immunity following a booster dose of Haemophilus influenzae type B-meningococcal serogroup C glycoconjugate vaccine: Follow-up of a randomized controlled trial
-
Khatami, A., et al. 2011. Persistence of immunity following a booster dose of Haemophilus influenzae type B-meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial. Pediatr. Infect. Dis. J. 30:197-202.
-
(2011)
Pediatr. Infect. Dis. J.
, vol.30
, pp. 197-202
-
-
Khatami, A.1
-
14
-
-
40549089883
-
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity
-
DOI 10.1086/527401
-
Maiden, M. C., et al. 2008. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J. Infect. Dis. 197:737-743. (Pubitemid 351364476)
-
(2008)
Journal of Infectious Diseases
, vol.197
, Issue.5
, pp. 737-743
-
-
Maiden, M.C.J.1
Ibarz-Pavon, A.B.2
Urwin, R.3
Gray, S.J.4
Andrews, N.J.5
Clarke, S.C.6
Walker, A.M.7
Evans, M.R.8
Kroll, J.S.9
Neal, K.R.10
Ala'Aldeen, D.A.A.11
Crook, D.W.12
Cann, K.13
Harrison, S.14
Cunningham, R.15
Baxter, D.16
Kaczmarski, E.17
MacLennan, J.18
Cameron, J.C.19
Stuart, J.M.20
more..
-
15
-
-
0342891343
-
Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays
-
Maslanka, S. E., et al. 1997. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin. Diagn. Lab. Immunol. 4:156-167. (Pubitemid 27130227)
-
(1997)
Clinical and Diagnostic Laboratory Immunology
, vol.4
, Issue.2
, pp. 156-167
-
-
Maslanka, S.E.1
Gheesling, L.L.2
Libutti, D.E.3
Donaldson, K.B.J.4
Harakeh, H.S.5
Dykes, J.K.6
Arhin, F.F.7
Devi, S.J.N.8
Frasch, C.E.9
Huang, J.C.10
Kriz-Kuzemenska, P.11
Lemmon, R.D.12
Lorange, M.13
Peeters, C.C.A.M.14
Quataert, S.15
Tai, J.Y.16
Carlone, G.M.17
Mills, E.L.18
Ashton, F.E.19
Diepevaen, J.20
Bielecki, J.21
Bybel, M.22
Cloutier, M.23
Poolman, J.T.24
more..
-
16
-
-
65349110862
-
An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS)
-
National Advisory Committee on Immunization
-
National Advisory Committee on Immunization. 2009. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS). Can. Commun. Dis. Rep. 35:1-40.
-
(2009)
Can. Commun. Dis. Rep.
, vol.35
, pp. 1-40
-
-
-
17
-
-
77952993552
-
Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: A phase 4 clinical trial
-
Perrett, K. P., et al. 2010. Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial. Clin. Infect. Dis. 50:1601-1610.
-
(2010)
Clin. Infect. Dis.
, vol.50
, pp. 1601-1610
-
-
Perrett, K.P.1
-
18
-
-
0035799462
-
Meningococcal disease
-
Rosenstein, N. E., B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes. 2001. Meningococcal disease. N. Engl. J. Med. 344:1378-1388.
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 1378-1388
-
-
Rosenstein, N.E.1
Perkins, B.A.2
Stephens, D.S.3
Popovic, T.4
Hughes, J.M.5
-
19
-
-
67649491062
-
Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine
-
Sakou, I. I., et al. 2009. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine. Vaccine 27:4408-4411.
-
(2009)
Vaccine
, vol.27
, pp. 4408-4411
-
-
Sakou, I.I.1
-
20
-
-
13844254496
-
Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine
-
DOI 10.1097/01.inf.0000151029.58752.27
-
Snape, M. D., et al. 2005. Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine. Pediatr. Infect. Dis. J. 24:128-131. (Pubitemid 40250770)
-
(2005)
Pediatric Infectious Disease Journal
, vol.24
, Issue.2
, pp. 128-131
-
-
Snape, M.D.1
Kelly, D.F.2
Green, B.3
Moxon, E.R.4
Borrow, R.5
Pollard, A.J.6
-
21
-
-
47149093375
-
Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: Observational study
-
DOI 10.1136/bmj.39563.545255.AE
-
Snape, M. D., et al. 2008. Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study. BMJ 336:1487-1491. (Pubitemid 351977021)
-
(2008)
BMJ
, vol.336
, Issue.7659
, pp. 1487-1491
-
-
Snape, M.D.1
Kelly, D.F.2
Lewis, S.3
Banner, C.4
Kibwana, L.5
Moore, C.E.6
Diggle, L.7
John, T.8
Yu, L.M.9
Borrow, R.10
Borkowski, A.11
Nau, C.12
Pollard, A.J.13
-
22
-
-
33751555760
-
Serogroup C meningococcal glycoconjugate vaccine in adolescents: Persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
-
DOI 10.1086/508776
-
Snape, M. D., et al. 2006. Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization. Clin. Infect. Dis. 43:1387-1394. (Pubitemid 44845637)
-
(2006)
Clinical Infectious Diseases
, vol.43
, Issue.11
, pp. 1387-1394
-
-
Snape, M.D.1
Kelly, D.F.2
Salt, P.3
Green, S.4
Snowden, C.5
Diggle, L.6
Borkowski, A.7
Yu, L.-M.8
Moxon, E.R.9
Pollard, A.J.10
-
23
-
-
0037424112
-
Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era
-
DOI 10.1016/S0264-410X(02)00630-8, PII S0264410X02006308
-
Trotter, C., R. Borrow, N. Andrews, and E. Miller. 2003. Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era. Vaccine 21:1094-1098. (Pubitemid 36139939)
-
(2003)
Vaccine
, vol.21
, Issue.11-12
, pp. 1094-1098
-
-
Trotter, C.1
Borrow, R.2
Andrews, N.3
Miller, E.4
-
24
-
-
3242768475
-
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
-
DOI 10.1016/S0140-6736(04)16725-1, PII S0140673604167251
-
Trotter, C. L., N. J. Andrews, E. B. Kaczmarski, E. Miller, and M. E. Ramsay. 2004. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364:365-367. (Pubitemid 38970013)
-
(2004)
Lancet
, vol.364
, Issue.9431
, pp. 365-367
-
-
Trotter, C.L.1
Andrews, N.J.2
Kaczmarski, E.B.3
Miller, E.4
Ramsay, M.E.5
-
25
-
-
21244452423
-
Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination
-
DOI 10.1093/aje/kwi160
-
Trotter, C. L., N. J. Gay, and W. J. Edmunds. 2005. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am. J. Epidemiol. 162:89-100. (Pubitemid 40885005)
-
(2005)
American Journal of Epidemiology
, vol.162
, Issue.1
, pp. 89-100
-
-
Trotter, C.L.1
Gay, N.J.2
Edmunds, W.J.3
|